These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 21478551

  • 1. Secretoglobin 3A2 suppresses bleomycin-induced pulmonary fibrosis by transforming growth factor beta signaling down-regulation.
    Kurotani R, Okumura S, Matsubara T, Yokoyama U, Buckley JR, Tomita T, Kezuka K, Nagano T, Esposito D, Taylor TE, Gillette WK, Ishikawa Y, Abe H, Ward JM, Kimura S.
    J Biol Chem; 2011 Jun 03; 286(22):19682-92. PubMed ID: 21478551
    [Abstract] [Full Text] [Related]

  • 2. Secretoglobin 3A2 Exhibits Anti-Fibrotic Activity in Bleomycin-Induced Pulmonary Fibrosis Model Mice.
    Cai Y, Kimura S.
    PLoS One; 2015 Jun 03; 10(11):e0142497. PubMed ID: 26559674
    [Abstract] [Full Text] [Related]

  • 3. Transgenically-expressed secretoglobin 3A2 accelerates resolution of bleomycin-induced pulmonary fibrosis in mice.
    Cai Y, Yoneda M, Tomita T, Kurotani R, Okamoto M, Kido T, Abe H, Mitzner W, Guha A, Kimura S.
    BMC Pulm Med; 2015 Jul 16; 15():72. PubMed ID: 26178733
    [Abstract] [Full Text] [Related]

  • 4. Preclinical evaluation of human secretoglobin 3A2 in mouse models of lung development and fibrosis.
    Cai Y, Winn ME, Zehmer JK, Gillette WK, Lubkowski JT, Pilon AL, Kimura S.
    Am J Physiol Lung Cell Mol Physiol; 2014 Jan 01; 306(1):L10-22. PubMed ID: 24213919
    [Abstract] [Full Text] [Related]

  • 5. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
    Nie Y, Zhang D, Jin Z, Li B, Wang X, Che H, You Y, Qian X, Zhang Y, Zhao P, Chai G.
    Clin Exp Pharmacol Physiol; 2019 Jun 01; 46(6):575-586. PubMed ID: 30854687
    [Abstract] [Full Text] [Related]

  • 6. A novel inhibitor of Smad-dependent transcriptional activation suppresses tissue fibrosis in mouse models of systemic sclerosis.
    Hasegawa M, Matsushita Y, Horikawa M, Higashi K, Tomigahara Y, Kaneko H, Shirasaki F, Fujimoto M, Takehara K, Sato S.
    Arthritis Rheum; 2009 Nov 01; 60(11):3465-75. PubMed ID: 19877032
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment effects of the traditional Chinese medicine Shenks in bleomycin-induced lung fibrosis through regulation of TGF-beta/Smad3 signaling and oxidative stress.
    Chu H, Shi Y, Jiang S, Zhong Q, Zhao Y, Liu Q, Ma Y, Shi X, Ding W, Zhou X, Cui J, Jin L, Guo G, Wang J.
    Sci Rep; 2017 May 22; 7(1):2252. PubMed ID: 28533545
    [Abstract] [Full Text] [Related]

  • 12. Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen.
    Ponticos M, Holmes AM, Shi-wen X, Leoni P, Khan K, Rajkumar VS, Hoyles RK, Bou-Gharios G, Black CM, Denton CP, Abraham DJ, Leask A, Lindahl GE.
    Arthritis Rheum; 2009 Jul 22; 60(7):2142-55. PubMed ID: 19565505
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MicroRNA-101 attenuates pulmonary fibrosis by inhibiting fibroblast proliferation and activation.
    Huang C, Xiao X, Yang Y, Mishra A, Liang Y, Zeng X, Yang X, Xu D, Blackburn MR, Henke CA, Liu L.
    J Biol Chem; 2017 Oct 06; 292(40):16420-16439. PubMed ID: 28726637
    [Abstract] [Full Text] [Related]

  • 15. Sustained activation of fibroblast transforming growth factor-beta/Smad signaling in a murine model of scleroderma.
    Takagawa S, Lakos G, Mori Y, Yamamoto T, Nishioka K, Varga J.
    J Invest Dermatol; 2003 Jul 06; 121(1):41-50. PubMed ID: 12839562
    [Abstract] [Full Text] [Related]

  • 16. BACH1 transcriptionally upregulates FOSL2 to induce M2 macrophages phenotype by activating TGFβ/SMAD signaling to promote the transformation of lung fibroblasts into myofibroblasts.
    Liu Y, Li X, Yang Y.
    Tissue Cell; 2024 Jun 06; 88():102407. PubMed ID: 38776730
    [Abstract] [Full Text] [Related]

  • 17. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis.
    Chang CJ, Lin CF, Lee CH, Chuang HC, Shih FC, Wan SW, Tai C, Chen CL.
    Biochem Pharmacol; 2021 Jan 06; 183():114356. PubMed ID: 33285108
    [Abstract] [Full Text] [Related]

  • 18. Secretoglobin 3A2 protects lung from developing cigarette smoke-induced pulmonary emphysema.
    Kurotani R, Ono S, Miyano Y, Nakayama S, Liu H, Aibara D, Sakahara S, Sato M, Sato K, Inoue S, Shibata Y, Lee MP, Abe H, Kimura S.
    Int J Biochem Cell Biol; 2023 Apr 06; 157():106390. PubMed ID: 36796505
    [Abstract] [Full Text] [Related]

  • 19. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway.
    Wen X, Liu Y, Bai Y, Li M, Fu Q, Zheng Y.
    Int J Mol Med; 2018 Dec 06; 42(6):3530-3541. PubMed ID: 30320382
    [Abstract] [Full Text] [Related]

  • 20. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
    Ji Y, Dou YN, Zhao QW, Zhang JZ, Yang Y, Wang T, Xia YF, Dai Y, Wei ZF.
    Acta Pharmacol Sin; 2016 Jun 06; 37(6):794-804. PubMed ID: 27133302
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.